ATE439443T1 - NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON - Google Patents
NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVONInfo
- Publication number
- ATE439443T1 ATE439443T1 AT06752809T AT06752809T ATE439443T1 AT E439443 T1 ATE439443 T1 AT E439443T1 AT 06752809 T AT06752809 T AT 06752809T AT 06752809 T AT06752809 T AT 06752809T AT E439443 T1 ATE439443 T1 AT E439443T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide derivatives
- new
- binding protein
- disease
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69124805P | 2005-06-17 | 2005-06-17 | |
| PCT/CA2006/000990 WO2006133566A1 (en) | 2005-06-17 | 2006-06-16 | NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE439443T1 true ATE439443T1 (de) | 2009-08-15 |
Family
ID=37531931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06752809T ATE439443T1 (de) | 2005-06-17 | 2006-06-16 | NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8323925B2 (de) |
| EP (1) | EP1896588B1 (de) |
| AT (1) | ATE439443T1 (de) |
| CA (1) | CA2611054C (de) |
| DE (1) | DE602006008460D1 (de) |
| ES (1) | ES2329511T3 (de) |
| WO (1) | WO2006133566A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0803912D0 (en) * | 2008-02-29 | 2008-05-07 | Univ Bristol | Novel Uses of VEGFxxxb |
| GB0804496D0 (en) * | 2008-03-11 | 2008-04-16 | Theryte Ltd | Treating cancer |
| CN103443125B (zh) | 2010-11-30 | 2019-05-03 | 霍夫曼-拉罗奇有限公司 | 低亲和力血脑屏障受体抗体及其用途 |
| WO2017083700A1 (en) * | 2015-11-13 | 2017-05-18 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | Ligand-guided phagocytosis based therapy for treatment of alzheimer's disease and other neurodegenerative diseases |
| JP7449092B2 (ja) * | 2017-01-30 | 2024-03-13 | ナショナル リサーチ カウンシル オブ カナダ | 血液脳関門移動化合物及びその使用 |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| WO2021097360A1 (en) | 2019-11-15 | 2021-05-20 | University Of Tennessee Research Foundation | Modified immunoglobulins for targeting amyloid deposits |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| WO2022093684A1 (en) * | 2020-10-30 | 2022-05-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods of treating inflammatory lung diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5385915A (en) | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
| AU2001263006A1 (en) * | 2000-05-18 | 2001-11-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| AU2002304814A1 (en) * | 2001-03-14 | 2002-11-05 | Hybrigenics | Protein-protein interactions in adipocytes |
| WO2003062391A2 (en) * | 2002-01-18 | 2003-07-31 | Incyte Corporation | Structural and cytoskeleton-associated proteins |
-
2006
- 2006-06-16 AT AT06752809T patent/ATE439443T1/de not_active IP Right Cessation
- 2006-06-16 ES ES06752809T patent/ES2329511T3/es not_active Expired - Lifetime
- 2006-06-16 WO PCT/CA2006/000990 patent/WO2006133566A1/en not_active Ceased
- 2006-06-16 US US11/921,219 patent/US8323925B2/en active Active
- 2006-06-16 EP EP06752809A patent/EP1896588B1/de not_active Expired - Lifetime
- 2006-06-16 CA CA2611054A patent/CA2611054C/en not_active Expired - Lifetime
- 2006-06-16 DE DE602006008460T patent/DE602006008460D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1896588A1 (de) | 2008-03-12 |
| CA2611054A1 (en) | 2006-12-21 |
| WO2006133566A1 (en) | 2006-12-21 |
| ES2329511T3 (es) | 2009-11-26 |
| EP1896588A4 (de) | 2008-08-20 |
| US8323925B2 (en) | 2012-12-04 |
| EP1896588B1 (de) | 2009-08-12 |
| US20110300141A1 (en) | 2011-12-08 |
| DE602006008460D1 (de) | 2009-09-24 |
| CA2611054C (en) | 2017-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123952T1 (el) | Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α | |
| EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| ATE464303T1 (de) | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen | |
| MX2007013626A (es) | Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos. | |
| WO2007137237A3 (en) | Treatment of protein misfolding | |
| CL2011003122A1 (es) | Anticuerpo que se une a la proteina tau fosforilada en la serina 422 (tau ps422), pero no se une a la tau ni al fragmento mcak fosforilado; acido nucleico que lo codifica; metodo de produccion; composicion farmaceutica; y uso util en el tratamiento de una tauopatia, tal como la enfermedad de alzheimer. | |
| WO2005123048A3 (en) | Screening methods using c-abl, fyn and syk in combination with tau protein | |
| UA107490C2 (uk) | TNF-α-ЗВ'ЯЗУВАЛЬНИЙ БІЛОК | |
| BRPI0911482A2 (pt) | Uso de epotilona d no tratamento de doenças associadas a tau incluindo doenças de alzheimer | |
| NO20064059L (no) | Albumin fusjonsproteiner | |
| EA201100070A1 (ru) | Туберкулезный белок rv2386c, композиции и их применения | |
| MX2008001865A (es) | Proteinas de fusion de albumina. | |
| EA200801509A1 (ru) | Человеческие моноклональные антитела к протеинтирозинкиназе 7 ( ptk7) и способы применения антител против ptk7 | |
| DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| WO2007044323A3 (en) | Fusion proteins for blood-brain barrier delivery | |
| MX2009002816A (es) | Proteinas de fusion de albumina. | |
| CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| AR047729A1 (es) | Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe) | |
| AR069860A1 (es) | Metodo para purificar un anticuerpo cd20 | |
| EA200970694A1 (ru) | ПЭГИЛИРОВАННЫЕ Fab-ФРАГМЕНТЫ АНТИТЕЛ К ПЕПТИДУ Aβ | |
| EA201100071A1 (ru) | Новые композиции и способы | |
| ATE432281T1 (de) | Pyrrolotriazin-kinasehemmer | |
| ATE458746T1 (de) | Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |